105 related articles for article (PubMed ID: 27323159)
1. Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro.
Zhang Q; Jin Y; Zhao CF; Wang WJ; Liu GY
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323159
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of receptor for advanced glycation end products (RAGE) in ovarian cancer.
Rahimi F; Karimi J; Goodarzi MT; Saidijam M; Khodadadi I; Razavi AN; Nankali M
Cancer Biomark; 2017; 18(1):61-68. PubMed ID: 27814276
[TBL] [Abstract][Full Text] [Related]
3. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
5. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
6. Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells.
Xu X; Wang B; Xu Y
Int J Oncol; 2013 Nov; 43(5):1578-86. PubMed ID: 23970168
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRAF4 expression suppresses osteosarcoma cell growth in vitro and in vivo.
Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
Int J Mol Med; 2014 Dec; 34(6):1655-60. PubMed ID: 25270078
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
9. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
10. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
11. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
[TBL] [Abstract][Full Text] [Related]
13. SND1 promotes the proliferation of osteosarcoma cells by upregulating COX‑2/PGE2 expression via activation of NF‑κB.
Zhou M; Wang A; Yin B; Wu D; Han S; Zhang W; Liu J; Sun K
Oncol Rep; 2019 Jan; 41(1):579-589. PubMed ID: 30365124
[TBL] [Abstract][Full Text] [Related]
14. ARID3A regulates autophagy related gene BECN1 expression and inhibits proliferation of osteosarcoma cells.
Parlayan C; Sahin Y; Altan Z; Arman K; Ikeda MA; Saadat KASM
Biochem Biophys Res Commun; 2021 Dec; 585():89-95. PubMed ID: 34801937
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
17. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic relevance of PRAME in primary osteosarcoma.
Tan P; Zou C; Yong B; Han J; Zhang L; Su Q; Yin J; Wang J; Huang G; Peng T; Shen J
Biochem Biophys Res Commun; 2012 Mar; 419(4):801-8. PubMed ID: 22390931
[TBL] [Abstract][Full Text] [Related]
19. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
